Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017 Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2017 Study

Carregando...
Imagem de Miniatura
Citações na Scopus
162
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
REINER JR., Robert C.
OLSEN, Helen Elizabeth
IKEDA, Chad Thomas
ECHKO, Michelle M.
BALLESTREROS, Katherine E.
MANGUERRA, Helen
MARTOPULLO, Ira
MILLEAR, Anoushka
SHIELDS, Chloe
SMITH, Alison
Citação
JAMA PEDIATRICS, v.173, n.6, article ID e190337, 17p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IMPORTANCE Understanding causes and correlates of health loss among children and adolescents can identify areas of success, stagnation, and emerging threats and thereby facilitate effective improvement strategies. OBJECTIVE To estimate mortality and morbidity in children and adolescents from 1990 to 2017 by age and sex in 195 countries and territories. DESIGN, SETTING, AND PARTICIPANTS This study examined levels, trends, and spatiotemporal patterns of cause-specific mortality and nonfatal health outcomes using standardized approaches to data processing and statistical analysis. It also describes epidemiologic transitions by evaluating historical associations between disease indicators and the Socio-Demographic Index (SDI), a composite indicator of income, educational attainment, and fertility. Data collected from 1990 to 2017 on children and adolescents from birth through 19 years of age in 195 countries and territories were assessed. Data analysis occurred from January 2018 to August 2018. EXPOSURES Being under the age of 20 years between 1990 and 2017. MAIN OUTCOMES AND MEASURES Death and disability. All-cause and cause-specific deaths, disability-adjusted life years, years of life lost, and years of life lived with disability. RESULTS Child and adolescent deaths decreased 51.7% from 13.77 million (95% uncertainty interval [UI], 13.60-13.93 million) in 1990 to 6.64 million (95% UI, 6.44-6.87 million) in 2017, but in 2017, aggregate disability increased 4.7% to a total of 145 million (95% UI, 107-190 million) years lived with disability globally. Progress was uneven, and inequity increased, with low-SDI and low-middle-SDI locations experiencing 82.2%(95% UI, 81.6%-82.9%) of deaths, up from 70.9%(95% UI, 70.4%-71.4%) in 1990. The leading disaggregated causes of disability-adjusted life years in 2017 in the low-SDI quintile were neonatal disorders, lower respiratory infections, diarrhea, malaria, and congenital birth defects, whereas neonatal disorders, congenital birth defects, headache, dermatitis, and anxiety were highest-ranked in the high-SDI quintile. CONCLUSIONS AND RELEVANCE Mortality reductions over this 27-year period mean that children are more likely than ever to reach their 20th birthdays. The concomitant expansion of nonfatal health loss and epidemiological transition in children and adolescents, especially in low-SDI and middle-SDI countries, has the potential to increase already overburdened health systems, will affect the human capital potential of societies, and may influence the trajectory of socioeconomic development. Continued monitoring of child and adolescent health loss is crucial to sustain the progress of the past 27 years.
Palavras-chave
Referências
  1. Akseer N, 2016, LANCET GLOB HEALTH, V4, pE395, DOI 10.1016/S2214-109X(16)30002-X
  2. Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6
  3. Anestis MD, 2017, PREV MED, V100, P159, DOI 10.1016/j.ypmed.2017.04.032
  4. Barros AJD, 2016, LANCET GLOB HEALTH, V4, pE873, DOI 10.1016/S2214-109X(16)30298-4
  5. Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
  6. Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003
  7. Davaasambuu S, 2017, CRISIS, V38, P330, DOI 10.1027/0227-5910/a000447
  8. Dicker D, 2018, LANCET, V392, P1684, DOI [10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9]
  9. Dieleman JL, 2017, LANCET, V389, P2005, DOI 10.1016/S0140-6736(17)30873-5
  10. Engmann Cyril M, 2016, PLoS Med, V13, pe1001969, DOI 10.1371/journal.pmed.1001969
  11. Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8
  12. Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X
  13. Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164
  14. Halfon N, 2007, HEALTH AFFAIR, V26, P315, DOI 10.1377/hlthaff.26.2.315
  15. James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7
  16. Keats EC, 2017, LANCET GLOB HEALTH, V5, pE782, DOI 10.1016/S2214-109X(17)30246-2
  17. King CA, 2018, CURR OPIN PSYCHOL, V22, P89, DOI 10.1016/j.copsyc.2017.08.037
  18. Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882
  19. Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]
  20. Lee ACK, 2014, EMERG MED J, V31, pE78, DOI 10.1136/emermed-2013-203298
  21. Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035
  22. Lozano R, 2018, LANCET, V392, P2091, DOI [10.1016/S0140-6736(18)32281-5, 10.1016/s0140-6736(18)32281-5]
  23. Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064
  24. Martinez-Alvarez M, 2017, HEALTH AFFAIR, V36, P1876, DOI 10.1377/hlthaff.2017.0364
  25. McMahon EM, 2017, BJPSYCH OPEN, V3, P291, DOI 10.1192/bjpo.bp.117.005322
  26. Minkovitz CS, 2002, AMBUL PEDIATR, V2, P85, DOI 10.1367/1539-4409(2002)002<0085:ABMACH>2.0.CO;2
  27. Mori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119772
  28. Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]
  29. Niranjjan R, 2018, INT J COMMUNITY MED, V5, P1109, DOI [10.18203/2394-6040.ijcmph20180769, DOI 10.18203/2394-6040.IJCMPH20180769]
  30. Paschall MJ, 2018, PREV MED, V106, P209, DOI 10.1016/j.ypmed.2017.11.004
  31. Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759
  32. Peden Margie, 2005, Int J Inj Contr Saf Promot, V12, P85, DOI 10.1080/15660970500086130
  33. Penchaszadeh V B, 1999, Community Genet, V2, P196, DOI 10.1159/000016212
  34. Ranger N., 2013, DISASTER RESILIENCE
  35. Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7
  36. Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
  37. Sen AC, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.002935
  38. Shretta R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1890-0
  39. Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971
  40. Slama S, 2017, LANCET, V389, P326, DOI 10.1016/S0140-6736(16)31404-0
  41. Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]
  42. Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]
  43. Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
  44. United Nations, 2018, SDG IND GLOB IND FRA
  45. Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
  46. Vos T, 2013, LANCET, V381, P628